商誉减值

Search documents
3亿多买亏损上亿公司!400亿晶晨股份增长放缓,港股IPO还稳吗?
Sou Hu Cai Jing· 2025-09-20 10:38
市值400亿的晶晨股份,正铆着劲冲港股IPO,可业绩却先踩了刹车,营收和净利润增速肉眼可见地往 下掉。偏偏这节骨眼上,它掏出3亿多,买下了一家一年半亏超1.3亿、营收刚够67万的公司。难道要栽 在这笔收购上? 你有没有过这样的困惑?明明手里攥着一副不算差的牌,却偏要在关键局押上奇怪的赌注。晶晨股份这 波操作,简直把这种困惑拉满了! 市值400亿的上市公司,正冲刺港股IPO的节骨眼上,居然砸3.16亿去买一家一年半亏超1.3亿、营收刚 够67万的公司,这哪是收购,分明是一场让人捏把汗的豪赌! 最离谱的还不是花钱买亏损,是这笔交易里的股权对价,简直颠覆认知! 甩掉债务雷,避开资金链断裂的坑,哪还顾得上赚多少。机构股东更划算,3.16亿的收购款刚好cover当 初的出资额,保本离场,笑得都合不拢嘴!可最让人想不通的,是晶晨股份图啥? 要知道,现在正是它港股IPO的攻坚期啊!这时候公司本该把报表扮得漂漂亮亮,好抬高估值才对。可 上半年财报一出来,增速明显掉下来了。 2024年上半年营收还能涨28.33%,2025年就只剩10.42%;净利润增速更是从96.06%跌到37.12%。增速 放缓的节骨眼上,不琢磨怎么稳住增 ...
上市超募后仅两年,业绩大变脸,现要再次募资19亿元……
IPO日报· 2025-09-19 00:34
Core Viewpoint - Jiujiang Defu Technology Co., Ltd. (Defu Technology) plans to issue up to 189 million shares to raise no more than 1.93 billion yuan, primarily for acquiring 100% equity of Circuit Foil Luxembourg S.a.r.l. and funding electronic chemical projects and working capital [1][6][8]. Group 1: Fundraising and Acquisition - The planned fundraising includes 1.43 billion yuan for acquiring Circuit Foil Luxembourg, 200 million yuan for electronic chemical projects, and 300 million yuan for working capital [1][6]. - Circuit Foil Luxembourg specializes in high-end electronic circuit copper foil, with applications in AI servers, 5G base stations, and mobile terminals, maintaining stable partnerships with leading PCB companies [4][6]. - The acquisition price of Circuit Foil Luxembourg is set at 1.74 billion euros, which is above its net asset value of approximately 1.26 billion euros, indicating potential goodwill formation post-acquisition [6][10]. Group 2: Financial Performance - Circuit Foil Luxembourg reported revenues of 13.37 million euros in 2024 and 4.5 million euros in Q1 2025, with a net loss of 370,000 euros in 2024, but a profit of 167,000 euros in Q1 2025 due to improved product volume and cost management [5][6]. - Defu Technology's financial performance has been volatile, with a revenue of 7.805 billion yuan in 2024, a decline in net profit to -245 million yuan, but a recovery in H1 2025 with revenue of 5.299 billion yuan and a net profit of 38.7 million yuan [10]. Group 3: Industry Context - The copper foil industry is capital-intensive, characterized by high fixed asset investments and significant R&D costs, which has led to a high debt ratio of 73.55% for Defu Technology as of June 30, 2025 [9][10]. - The company aims to enhance its capital structure and operational efficiency through this fundraising, addressing the growing working capital needs driven by increasing sales [9][10].
业绩三连降,25亿元商誉高悬:东诚药业分拆“烧钱核药”赴港续命|创新药观察
Hua Xia Shi Bao· 2025-09-18 12:19
Core Viewpoint - Dongcheng Pharmaceutical's decision to spin off its subsidiary, Lanacheng, for a Hong Kong listing is interpreted as a "passive self-rescue" amid ongoing performance pressure and significant financial liabilities [2][14]. Financial Performance - The company has experienced a continuous decline in revenue from 2022 to 2024, with decreases of 8.41%, 8.58%, and 12.42% respectively; net profit attributable to shareholders also fell by 31.75% and 12.35% in 2023 and 2024 [4]. - In the first half of 2025, the company reported revenue of 1.384 billion yuan, a year-on-year decrease of 2.60%, and a net profit of 88.65 million yuan, down 20.70% [7]. Business Segmentation - The traditional raw material drug business remains the largest revenue source but has seen its proportion drop below 50% for the first time in 2024; in the first half of 2025, revenue from raw material drugs fell by 7.02% [4][5]. - The nuclear medicine segment, while showing a slight revenue increase of 0.78% to 503 million yuan in the first half of 2025, has experienced a decline in gross margin from 72.95% to 67.27% [5]. Subsidiary Overview - Lanacheng, the subsidiary being spun off, focuses on innovative radioactive diagnostic and therapeutic drugs but has not generated any revenue since its establishment; it recorded net losses of 38 million yuan, 99 million yuan, and 180 million yuan from 2022 to 2024 [11]. - The company has a significant R&D expenditure, reaching 431 million yuan in 2024, with 86.62% allocated to nuclear medicine research [11]. Goodwill and Risks - Dongcheng Pharmaceutical faces substantial goodwill risks, with a goodwill balance of 2.499 billion yuan, accounting for 55.7% of net assets; this goodwill primarily stems from previous acquisitions in the nuclear medicine sector [15]. - The company has a history of goodwill impairment related to past acquisitions, indicating ongoing risks associated with its growth strategy [16].
琻捷电子冲刺IPO:花上亿元买的资产 次年就商誉减值超7000万元 交易对手还是公司间接股东
Mei Ri Jing Ji Xin Wen· 2025-09-18 09:24
近日,车规级芯片公司琻捷电子科技(江苏)股份有限公司(以下简称琻捷电子)向港交所递交招股书(申请版本,下同),以上市规则第18C章项下特专 科技公司身份寻求上市。 记者注意到,在报告期内(2022年至2024年各年度与2025年上半年,下同),作为琻捷电子股东旗下附属公司的客户F,逐步成为琻捷电子第一大客户。今 年上半年,来自客户F的销售收入已占琻捷电子总收入的20%以上,而且是琻捷电子前五大客户中唯一一家直销商。 此外,琻捷电子在2022年以总价超1亿元收购了聚洵半导体科技(上海)有限公司(以下简称聚洵半导体)100%股权,转让方包括科隆股份 (300405.SZ)、张智才等。然而,琻捷电子到了2023年即对聚洵半导体计提了商誉减值准备7610万元。 值得一提的是,在上述股权交易正式完成前的2022年4月、9月,张智才等多名交易对手正式成为琻捷电子的间接股东。 另一方面,2021年入股聚洵半导体的科隆股份,在2022年通过转让上述股权产生收益2307万元。 琻捷电子分销商数量为何自2024年起大幅减少? 根据招股书,按2024年收入计,琻捷电子为全球第三大汽车无线传感SoC(系统级芯片)公司,也是中国最大的 ...
琻捷电子冲刺IPO:花上亿元买的资产,次年就商誉减值超7000万元,交易对手还是公司间接股东
Mei Ri Jing Ji Xin Wen· 2025-09-18 09:08
每经记者|王琳 每经编辑|文多 近日,车规级芯片公司琻捷电子科技(江苏)股份有限公司(以下简称琻捷电子)向港交所递交招股书(申请版本,下同),以上市规则第18C章项下特专 科技公司身份寻求上市。 记者注意到,在报告期内(2022年至2024年各年度与2025年上半年,下同),作为琻捷电子股东旗下附属公司的客户F,逐步成为琻捷电子第一大客户。今 年上半年,来自客户F的销售收入已占琻捷电子总收入的20%以上,而且是琻捷电子前五大客户中唯一一家直销商。 此外,琻捷电子在2022年以总价超1亿元收购了聚洵半导体科技(上海)有限公司(以下简称聚洵半导体)100%股权,转让方包括科隆股份 (300405.SZ)、张智才等。然而,琻捷电子到了2023年即对聚洵半导体计提了商誉减值准备7610万元。 值得一提的是,在上述股权交易正式完成前的2022年4月、9月,张智才等多名交易对手正式成为琻捷电子的间接股东。 另一方面,2021年入股聚洵半导体的科隆股份,在2022年通过转让上述股权产生收益2307万元。 值得一提的是,客户F是琻捷电子股东旗下附属公司。客户F在2024年和2025年上半年都是琻捷电子的第一大客户,为琻捷电子 ...
捷强装备推4690万跨界并购 标的估值溢价1656%承诺三年赚5500万
Chang Jiang Shang Bao· 2025-09-18 07:35
Core Viewpoint - The company, Jieqiang Equipment, is facing ongoing performance pressure and plans to enter the nano-carbon materials sector through the acquisition of Shandong Tanxun New Materials Co., Ltd. for 46.9 million yuan, acquiring a 51% stake [1][4]. Group 1: Acquisition Details - Jieqiang Equipment announced a plan to acquire 51% of Shandong Tanxun for 46.9 million yuan, with an overall valuation of 103 million yuan, reflecting a valuation increase of 1656.72% [1][4]. - The acquisition aims to diversify Jieqiang Equipment's business into the nano-carbon materials field, which is a significant strategic move for the company [1][4]. - Shandong Tanxun is expected to achieve a cumulative net profit of 55 million yuan from 2025 to 2027, with a commitment that no annual net profit will be negative during this period [1][5]. Group 2: Financial Performance - Jieqiang Equipment has reported a cumulative net loss of 372 million yuan over the past three and a half years, with a net loss of 86.87 million yuan in the first half of 2025 [3][9]. - The company's revenue for the first half of 2025 was 107 million yuan, showing a year-on-year increase of 1.44%, but the net profit decreased significantly compared to the previous year [8][9]. - The company has not distributed cash dividends since 2022, indicating ongoing financial challenges [9]. Group 3: Business Risks and Challenges - The acquisition comes amid high pressure on Jieqiang Equipment's core business, which has been struggling since its listing in August 2020, leading to significant losses in subsequent years [2][7]. - The high debt ratio of Shandong Tanxun, at 94.3%, raises concerns about the financial stability of the acquired entity [5][4]. - The company acknowledges the risks associated with entering a new business area and the potential for goodwill impairment if Shandong Tanxun's performance does not meet expectations [3][5].
星徽股份拟用15.38亿公积金补亏 净利四年半亏23.3亿负债率近90%
Chang Jiang Shang Bao· 2025-09-11 23:34
Core Viewpoint - Starway Co., Ltd. (300464.SZ) is attempting to cover its cumulative losses of 2.693 million yuan from surplus reserves and 1.511 billion yuan from capital reserves, totaling 1.538 billion yuan, amid continuous losses over the past four and a half years, amounting to a cumulative loss of 2.33 billion yuan [2][3][9]. Financial Performance - Starway's revenue has been declining consistently since 2021, with revenues of 3.660 billion yuan, 2.351 billion yuan, 1.626 billion yuan, and 1.510 billion yuan from 2021 to 2024, reflecting year-on-year declines of 33.74%, 35.77%, 30.85%, and 7.13% respectively [5]. - The net profit for the same period has been negative, with figures of -1.524 billion yuan, -260 million yuan, -76.09 million yuan, and -460 million yuan, showing a significant increase in losses in 2021 and a slight recovery in subsequent years [5]. - As of the end of 2024, the company's cumulative undistributed profits stood at -1.133 billion yuan, with surplus reserves of 2.693 million yuan and capital reserves of 1.511 billion yuan [3]. Debt and Equity Situation - As of mid-2025, Starway's debt-to-asset ratio reached 89.93%, indicating a high level of financial leverage [12]. - The debt-to-asset ratios from the end of 2021 to the end of 2024 were 81.77%, 92.52%, 70.52%, and 89.61% respectively, showing fluctuations but a generally high level of debt [11][12]. - The company's major shareholders have pledged a significant number of shares, with a total of 132 million shares pledged, accounting for 28.74% of the total share capital [16]. Shareholder Actions - Recently, a major shareholder, Guangdong Xingye Investment Co., Ltd., transferred 32 million shares, representing 6.99% of the total share capital, to another party at a price of 4.50 yuan per share [13]. - The controlling shareholder, Xie Xiaohua, has pledged 16 million shares, which is 15.65% of his holdings and 3.49% of the total share capital [14]. Business Operations - Starway primarily engages in the research, development, manufacturing, and sales of precision hardware components such as slides and hinges, as well as smart home appliances and related products [4]. - The company reported that its core competitiveness remains unchanged despite the ongoing financial difficulties [6].
罗曼股份跨界收购遭监管问询高溢价并购智算公司藏风险
Xin Lang Cai Jing· 2025-09-05 10:41
Core Viewpoint - Roman Co. has received a regulatory inquiry from the Shanghai Stock Exchange regarding its plan to acquire a 39.2308% stake in Shanghai Wutong Tree High-tech Co., Ltd. for 196 million yuan, which has raised significant market attention due to a staggering valuation increase of 1687.42% [1][2]. Group 1: Acquisition Details - The acquisition involves a cash payment of 196 million yuan for a stake in Wutong High-tech, a company established in December 2023, which operates in a completely different industry from Roman Co.'s main business of landscape lighting [1][2]. - Wutong High-tech reported a revenue of 32.941 million yuan and a net loss of 1.0857 million yuan for 2024, despite promising a cumulative net profit of no less than 400 million yuan from 2025 to 2027 [2]. - The valuation of Wutong High-tech was assessed at 513 million yuan using the income approach, resulting in a value increase of 484 million yuan compared to its book value [2]. Group 2: Risks and Concerns - The company has acknowledged several risks associated with the acquisition, including integration risks due to a lack of experience in the relevant industry [3]. - There is a significant risk of goodwill impairment, as the acquisition will create a large amount of goodwill on the balance sheet, which could negatively impact profits if the acquired company performs poorly [3]. - The ability to meet performance commitments is also in question, given Wutong High-tech's small business scale and low market share, which may hinder its ability to achieve expected revenues amid economic fluctuations [3]. - The performance compensation commitment from the guarantor, Shanghai Bahuang, is uncertain as it was established recently and has not completed capital contributions [3]. - The transaction structure is complex, involving "performance betting + share pledge," with Wutong's related party acquiring 5.04% of Roman Co.'s shares for 183 million yuan, pledged as performance compensation guarantee [3].
罗曼股份跨界收购遭监管问询 高溢价并购智算公司藏风险
Xin Lang Zheng Quan· 2025-09-05 09:38
Core Viewpoint - Roman Co. has received a regulatory inquiry from the Shanghai Stock Exchange regarding its plan to acquire a 39.2308% stake in Shanghai Wutong Tree High-tech Co., Ltd. for 196 million yuan, which values the company at 513 million yuan, reflecting a staggering appreciation rate of 1687.42% [1][2]. Group 1: Acquisition Details - The acquisition involves a high premium, as Roman Co. operates in the landscape lighting sector while Wutong High-tech is engaged in AIDC computing infrastructure integration services, indicating a significant industry divergence [2]. - Wutong High-tech, established only 20 months ago, reported a revenue of 32.941 million yuan and a net loss of 1.0857 million yuan for 2024, raising concerns about its financial viability [2]. - Despite its modest historical performance, Wutong High-tech has committed to achieving a cumulative net profit of no less than 400 million yuan from 2025 to 2027, which contrasts sharply with its current earnings [2]. Group 2: Risks and Concerns - Roman Co. has highlighted several risks associated with the acquisition, including integration challenges due to a lack of relevant industry management experience [3]. - The potential for goodwill impairment is significant, as the acquisition will create a large amount of goodwill on the balance sheet, which could adversely affect profits if Wutong High-tech's performance deteriorates [3]. - The risk of not meeting performance commitments is also a concern, given Wutong High-tech's small business scale and low market share, which could be impacted by macroeconomic fluctuations or changes in industry policy [3]. - The ability of the guarantor, Shanghai Bahuang, to fulfill its performance compensation commitments is uncertain, as it was only established recently and has not completed its capital contributions [3]. Group 3: Transaction Structure - The transaction is complex, involving a "performance betting + share pledge" structure, where Wutong's affiliates will acquire 5.04% of Roman Co. for 183 million yuan and pledge it as a performance compensation guarantee [4]. - Regulatory authorities have requested clarification on the basis and reasonableness of the performance commitments, as well as any potential conflicts of interest among the parties involved in the transaction [4].
渤海租赁(000415.SZ):上半年净亏损20.19亿元
Ge Long Hui A P P· 2025-08-29 14:19
Core Insights - Bohai Leasing (000415.SZ) reported a significant increase in revenue for the first half of 2025, achieving 28.46 billion yuan, a year-on-year growth of 75.91% [1] - The company experienced a net loss attributable to shareholders of 2.02 billion yuan, marking a shift from profit to loss compared to the previous year [1] - The decline in net profit was primarily due to an impairment loss of approximately 3.29 billion yuan related to the sale of GSCL's 100% equity, which was below its net asset value [1] Financial Performance - The company's net profit attributable to shareholders, excluding the impact of goodwill impairment, was 1.27 billion yuan, reflecting a year-on-year increase of 77.27% [2] - The net profit after excluding non-recurring gains and losses was 998 million yuan, showing an 87.42% increase compared to the previous year [2] - The growth in profitability was driven by strong global air passenger demand and limited production capacity from aircraft manufacturers, which maintained high market values, leasing rates, and renewal rates [2] Business Operations - The completion of the CAL 100% equity transfer contributed positively to the company's financial performance [2] - The company continued to optimize its fleet structure through aircraft asset sales, leading to an improvement in the average yield of its existing fleet [2] - The profitability of the aircraft leasing business increased compared to the same period last year [2]